G. Borrello et al., THE EFFECTS OF MAGNESIUM-OXIDE ON MILD ESSENTIAL-HYPERTENSION AND QUALITY-OF-LIFE, Current therapeutic research, 57(10), 1996, pp. 767-774
Citations number
20
Categorie Soggetti
Pharmacology & Pharmacy","Medicine, Research & Experimental
The role of magnesium (Mg) in the pathophysiology and treatment of pri
mary hypertension has been recently identified, To evaluate the effect
s of Mg supplementation on mild hypertension and quality of life, 83 p
atients were randomly assigned to receive either placebo (n = 41) or M
g (n = 42) after a placebo run-in phase of 4 weeks, The patients in th
e Mg group received 200 mg oral Mg oxide daily, All patients underwent
periodic measurements of blood pressure (BP) and heart rate and 24-ho
ur noninvasive BP monitoring at the start and end of the study, Serum
and urinary electrolytes were also evaluated, To analyze quality of li
fe, all patients completed the questionnaire, Treatment was administer
ed and the measurements of BP were performed in a double-masked fashio
n, Data demonstrated a significant reduction in systolic BP values at
12-week follow-up in patients treated with Rig compared with both the
pretreatment values and the values in the placebo group, whereas no di
fference was found in diastolic pressure, The 24-hour noninvasive moni
toring of BP showed no significant differences between the two groups
in systolic and diastolic values, The analysis of the questionnaire de
monstrated a lower score (indicating a good quality of life) with a Li
kert-type scale at 12-week follow-up in the Mg group (67.58 +/- 5) tha
n in the placebo group (78.23 +/- 8), with a corresponding significant
improvement in psychosocial variables, general well-being, and work s
tatus, A significant difference was also found in the treatment group
when the values at follow-up were compared with those at baseline (73.
58 +/- 6), These results show that Mg oxide positively influences the
quality of life, although it exercises only a weak action on arterial
BP.